drugset / Trial / NCT01434901
The Effects of Bethanechol on Glucose Homeostasis
Phase 1
Completed
50 enrolled
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collab
Non-randomizedCrossoverSingle-blindBasic science
Summary
Xenin-25 and glucose-dependent insulinotropic polypeptide (GIP) are hormones produced in the intestine that are released into the blood immediately after ingestion of a meal. Together, these 2 hormones increase insulin release and reduce blood glucose levels. Xenin-25 works by increasing acetylcholine release in pancreatic islets. This study will determine if a Bethanechol, a drug that is similar to acetylcholine, also increases insulin release and reduces blood glucose levels after ingestion of a mixed meal.
Timeline
- Start
- 2011-08-15
- Primary completion
- 2014-07-07
- Completion
- 2014-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bethanechol | Small molecule | 25 mg | Oral |
| Subject | Bethanechol | Small molecule | 50 mg | Oral |
| Subject | Bethanechol | Small molecule | 100 mg | Oral |